Gallstone showdown: which treatment wins?
NCT ID NCT07413068
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares three approaches for people with both gallstones and bile duct stones: a gallbladder-preserving procedure using an endoscope, ERCP plus gallbladder removal surgery, or conservative management with medication or watchful waiting. Researchers will track complications and success rates in 300 participants to see which option is safest and most effective. The goal is to help patients and doctors choose the best treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ursodeoxycholic acid
- What this could lead to
- If successful, this could show which treatment option is safest and most effective for people with both gallstones and bile duct stones, helping guide future care.
- What could go wrong
- This is an observational study based on patient preference, not random assignment, so results may be less reliable. It is also early-stage and may not lead to clear conclusions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLELITHIASIS ASSOCIATED WITH COMMON BILE DUCT STONES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250063, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.